Screening, referral and treatment of depression by Australian cardiologists
- Hare, David, Stewart, Andrew, Driscoll, Andrea, Mathews, Stephanie, Toukhsati, Samia
- Authors: Hare, David , Stewart, Andrew , Driscoll, Andrea , Mathews, Stephanie , Toukhsati, Samia
- Date: 2020
- Type: Text , Journal article
- Relation: Heart Lung and Circulation Vol. 29, no. 3 (2020), p. 401-404
- Full Text: false
- Reviewed:
- Description: Background: Depression is common in cardiovascular disease (CVD). Clinical practice guidelines recommend routine depression screening by cardiologists. The aim of the study was to undertake a national survey of Australian cardiologists’ clinical practice behaviours in relation to depression screening, referral, and treatment. Methods: The Cardiovascular Disease and Depression Questionnaire was sent to 827 eligible cardiologist members of Cardiac Society of Australia and New Zealand, of which a total of 524 were returned (63%). Results: Most Australian cardiologists do not routinely ask their patients about depression and only 3% routinely use depression screening instruments. Most cardiologists (>70%) think that General Practitioners (Primary Care Physicians) are primarily responsible for identifying and treating depression in CVD. Cardiologists, who understand the prognostic risks of depression in CVD and feel confident to identify and treat depression, were more likely to screen, refer and/or treat patients for depression. Conclusions: Australian cardiologists rarely use validated depression screening measures. Several brief instruments are available for use and can be easily integrated into routine patient care without taking additional consultation time. © 2019
- Description: This work was supported by the Beyond Blue Victorian Centre of Excellence in Depression and Anxiety. Prof Andrea Driscoll was supported by a Heart Foundation Future Leader fellowship 100472 from the National Heart Foundation of Australia.
Ballarat health consortium : A case study of influential factors in the development and maintenance of a health partnership
- McDonald, John, Murphy, Angela, Payne, Warren
- Authors: McDonald, John , Murphy, Angela , Payne, Warren
- Date: 2001
- Type: Text , Journal article
- Relation: Australian Journal of Primary Health Vol. 7, no. 2 (2001), p. 75-82
- Full Text:
- Reviewed:
- Description: Intersectoral partnerships in health have a central role in current policy and programs. Partnerships are seen to be an effective strategy for maximising health outcomes. However, theoretical models of health partnerships are underdeveloped. Moreover, the research literature contains inconsistent findings about their effectiveness, and there has been very little evaluative research on health partnerships in this country. This paper reports on a case study of an intersectoral consortium using a health promotion approach to cardiovascular disease. A model of partnership formation and development is presented. From this, a research strategy was devised and carried out. Results indicate that the health consortium was formed inresponse to a critical health issue, and as a separate legal entity without recurrent funding, it has been sustained through the commitment of individual members. Project funding has, in large part, dictated its operations. The case study reveals the strengths, vulnnerabilities and achievements of this consortium over five years. To produce sustainable health outcomes, the researchers conclude, partnerships require strategic management to capitalise on individual endeavours, organisational alignments, and government or funder priorities. Ideological zeal for intersectoral health partnerships must be balanced by rigorous evaluation; together with more sophisticated indicators for measuring success in partnerships in health promotion. Theoretical development of models of health partnerships will also contribute to their enhanced effectiveness.
- Description: 2003004325
- Authors: McDonald, John , Murphy, Angela , Payne, Warren
- Date: 2001
- Type: Text , Journal article
- Relation: Australian Journal of Primary Health Vol. 7, no. 2 (2001), p. 75-82
- Full Text:
- Reviewed:
- Description: Intersectoral partnerships in health have a central role in current policy and programs. Partnerships are seen to be an effective strategy for maximising health outcomes. However, theoretical models of health partnerships are underdeveloped. Moreover, the research literature contains inconsistent findings about their effectiveness, and there has been very little evaluative research on health partnerships in this country. This paper reports on a case study of an intersectoral consortium using a health promotion approach to cardiovascular disease. A model of partnership formation and development is presented. From this, a research strategy was devised and carried out. Results indicate that the health consortium was formed inresponse to a critical health issue, and as a separate legal entity without recurrent funding, it has been sustained through the commitment of individual members. Project funding has, in large part, dictated its operations. The case study reveals the strengths, vulnnerabilities and achievements of this consortium over five years. To produce sustainable health outcomes, the researchers conclude, partnerships require strategic management to capitalise on individual endeavours, organisational alignments, and government or funder priorities. Ideological zeal for intersectoral health partnerships must be balanced by rigorous evaluation; together with more sophisticated indicators for measuring success in partnerships in health promotion. Theoretical development of models of health partnerships will also contribute to their enhanced effectiveness.
- Description: 2003004325
The association between selected molecular biomarkers and ambulatory blood pressure patterns in African chronic kidney disease and hypertensive patients compared with normotensive controls : protocol for a longitudinal study
- Adeoye, Abiodun, Adebayo, Oladimeji, Abiola, Busayo, Iwalokun, Bamidele, Tayo, Bamidele, Charchar, Fadi, Ojo, Akinlolu, Cooper, Richard
- Authors: Adeoye, Abiodun , Adebayo, Oladimeji , Abiola, Busayo , Iwalokun, Bamidele , Tayo, Bamidele , Charchar, Fadi , Ojo, Akinlolu , Cooper, Richard
- Date: 2020
- Type: Text , Journal article
- Relation: JMIR Research Protocols Vol. 9, no. 1 (Jan 2020), p. 8
- Full Text:
- Reviewed:
- Description: Background: Chronic kidney disease (CKD) is a burgeoning epidemic in sub-Saharan Africa. Abnormal blood pressure variations are prevalent in CKD and potentiate the risk of cardiovascular morbidity and mortality. Certain genetic variants (angiotensin II receptor type 1 1166 A>C and angiotensin-converting enzyme insertion and deletion polymorphisms) and biomarkers such as interleukin-6, tumor necrosis factor, soluble (s) E-selectin, homocysteine, and highly sensitive C-reactive protein have been shown to affect blood pressure variability among non-African CKD, hypertensive. and nonhypertensive CKD population. However, the contributions of the pattern, genetic, and environmental determinants of ambulatory blood pressure in African CKD have not been characterized. Understanding these interactions may help to develop interventions to prevent major cardiovascular events among people with CKD. Objective: The overarching objective of this study is to identify, document, and develop approaches to address related phenomic, genetic, and environmental determinants of ambulatory blood pressure patterns in African CKD and non-CKD hypertensive patients compared with normotensive controls. Methods: This is a longitudinal short-term follow-up study of 200 adult subjects with CKD and 200 each of age-matched hypertensives without CKD and apparently healthy controls. Demographic information, detailed clinical profile, electrocardiography, echocardiography, and 24-hr ambulatory blood pressure measurements will be obtained. Blood samples will be collected to determine albumin-creatinine ratio, fasting plasma glucose, lipid profile, electrolytes, urea and creatinine, C-reactive protein, serum homocysteine, fibroblast growth factor-23, and complete blood count, while 2 mL blood aliquot will be collected in EDTA (ethylenediaminetetraacetic acid) tubes and mixed using an electronic rolling system to prevent blood clots and subsequently used for DNA extraction and genetic analysis. Results: A total of 239 participants have been recruited so far, and it is expected that the recruitment phase will be complete in June 2020. The follow-up phase will continue with data analysis and publications of results. Conclusions: This study will help stratify Nigerian CKD patients phenotypically and genotypically in terms of their blood pressure variations with implications for targeted interventions and timing of medications to improve prognosis.
- Authors: Adeoye, Abiodun , Adebayo, Oladimeji , Abiola, Busayo , Iwalokun, Bamidele , Tayo, Bamidele , Charchar, Fadi , Ojo, Akinlolu , Cooper, Richard
- Date: 2020
- Type: Text , Journal article
- Relation: JMIR Research Protocols Vol. 9, no. 1 (Jan 2020), p. 8
- Full Text:
- Reviewed:
- Description: Background: Chronic kidney disease (CKD) is a burgeoning epidemic in sub-Saharan Africa. Abnormal blood pressure variations are prevalent in CKD and potentiate the risk of cardiovascular morbidity and mortality. Certain genetic variants (angiotensin II receptor type 1 1166 A>C and angiotensin-converting enzyme insertion and deletion polymorphisms) and biomarkers such as interleukin-6, tumor necrosis factor, soluble (s) E-selectin, homocysteine, and highly sensitive C-reactive protein have been shown to affect blood pressure variability among non-African CKD, hypertensive. and nonhypertensive CKD population. However, the contributions of the pattern, genetic, and environmental determinants of ambulatory blood pressure in African CKD have not been characterized. Understanding these interactions may help to develop interventions to prevent major cardiovascular events among people with CKD. Objective: The overarching objective of this study is to identify, document, and develop approaches to address related phenomic, genetic, and environmental determinants of ambulatory blood pressure patterns in African CKD and non-CKD hypertensive patients compared with normotensive controls. Methods: This is a longitudinal short-term follow-up study of 200 adult subjects with CKD and 200 each of age-matched hypertensives without CKD and apparently healthy controls. Demographic information, detailed clinical profile, electrocardiography, echocardiography, and 24-hr ambulatory blood pressure measurements will be obtained. Blood samples will be collected to determine albumin-creatinine ratio, fasting plasma glucose, lipid profile, electrolytes, urea and creatinine, C-reactive protein, serum homocysteine, fibroblast growth factor-23, and complete blood count, while 2 mL blood aliquot will be collected in EDTA (ethylenediaminetetraacetic acid) tubes and mixed using an electronic rolling system to prevent blood clots and subsequently used for DNA extraction and genetic analysis. Results: A total of 239 participants have been recruited so far, and it is expected that the recruitment phase will be complete in June 2020. The follow-up phase will continue with data analysis and publications of results. Conclusions: This study will help stratify Nigerian CKD patients phenotypically and genotypically in terms of their blood pressure variations with implications for targeted interventions and timing of medications to improve prognosis.
- «
- ‹
- 1
- ›
- »